← Back to Search

Behavioral Intervention

Waitlist Control Group (WCG) for Substance Abuse (BrotherlyACT Trial)

N/A
Recruiting
Led By Chuka N Emezue, PhD, MPH
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1-, and 3-months post-intervention
Awards & highlights

BrotherlyACT Trial Summary

This trial aims to test a digital intervention specifically designed for young Black males to help reduce the risk and effects of youth violence and substance use. It will also help improve access to services in pediatric emergency and

Who is the study for?
This trial is for young Black males who may be at risk of or affected by youth violence and substance use. It aims to help those in low-resource communities, particularly those who visit pediatric emergency services.Check my eligibility
What is being tested?
The study is testing BrotherlyACT, a culturally tailored digital intervention designed to reduce youth violence and substance use among participants. The effectiveness will be compared with a waitlist control group that does not receive the intervention immediately.See study design
What are the potential side effects?
Since this is a digital and educational intervention rather than a medical treatment, traditional side effects are not applicable. However, there might be emotional or psychological impacts from discussing sensitive topics like violence and substance abuse.

BrotherlyACT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1-, and 3-months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1-, and 3-months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Attitude toward Substance Use
Drug Use Disorders Identification Test (DUDIT)
Multidimensional Peer Victimization Scale (MPVS)
+2 more
Secondary outcome measures
Emotional Avoidance Strategy Inventory for Adolescents (EASI-A)
Intensity-of-Care Measurements
The Kessler Psychological Distress Scale (K-10)
+2 more

BrotherlyACT Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist Control Group (WCG)Experimental Treatment1 Intervention
Waitlist Control Group (WCG)
Group II: BrotherlyACT Intervention GroupExperimental Treatment1 Intervention
Three components make up BrotherlyACT: 1) Brief psychoeducational modules adapted from an evidence-based violence prevention program; 2) A Safety Planning Toolkit offering tools for risk assessment, mood tracking, goal setting, and mindfulness-based stress reduction; 3) A Service Engagement Chatbot that uses NLP to provide zip-code based navigational support and talk therapy.

Find a Location

Who is running the clinical trial?

Rush University Medical CenterLead Sponsor
422 Previous Clinical Trials
163,201 Total Patients Enrolled
2 Trials studying Substance Abuse
35,601 Patients Enrolled for Substance Abuse
Chuka N Emezue, PhD, MPHPrincipal InvestigatorRush University Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals who are 60 years and older eligible to participate in this medical trial?

"Recruitment for this research study is targeting individuals aged 15 to 24 years."

Answered by AI

Am I eligible to partake in this clinical investigation?

"Individuals aged between 15 and 24 with a history of substance abuse are invited to apply for participation in this medical study. Approximately 300 individuals will be enrolled in the trial."

Answered by AI

Are prospective participants able to enroll in this research study at the present time?

"Affirmative. Information sourced from clinicaltrials.gov confirms the current recruitment status of this research endeavor. The study was initially disclosed on February 15th, 2024, and most recently revised on April 7th, 2024. In total, it aims to enroll a cohort of 300 individuals at one designated site."

Answered by AI
~200 spots leftby Feb 2026